Clinical Trial Update: Evaluate Safety/Tolerability in Portuguese Participants With RRMS Transitioning From Current Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating safety and tolerability in Portuguese participants with relapsing-remitting multiple sclerosis transitioning from current therap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: Biogen | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 4 | Status: COMPLETED